Trexquant Investment LP Rubius Therapeutics, Inc. Transaction History

Trexquant Investment LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.25 - $10.4 $74,183 - $181,532	-17,455 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.68 - $17.74 $85,822 - $157,282	-8,866 Reduced 33.68%	17,455 $169,000
Q3 2021 Nov 12, 2021	BUY	$17.6 - $25.91 $221,267 - $325,740	12,572 Added 91.44%	26,321 $471,000
Q2 2021 Aug 12, 2021	BUY	$22.26 - $28.43 $306,052 - $390,884	13,749 New	13,749 $336,000
Q1 2021 May 13, 2021	SELL	$8.02 - $32.01 $106,850 - $426,469	-13,323 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$4.23 - $8.73 $97,459 - $201,139	-23,040 Reduced 63.36%	13,323 $101,000
Q3 2020 Nov 06, 2020	BUY	$4.65 - $6.25 $31,252 - $42,006	6,721 Added 22.67%	36,363 $182,000
Q2 2020 Aug 07, 2020	BUY	$4.01 - $6.88 $118,864 - $203,936	29,642 New	29,642 $177,000
Q1 2020 May 08, 2020	SELL	$3.74 - $9.84 $103,743 - $272,951	-27,739 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$7.23 - $14.12 $200,552 - $391,674	27,739 New	27,739 $264,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.